Skip to main content
. 2011 Dec 6;42(1):8–28. doi: 10.1007/s00595-011-0075-7

Fig. 5.

Fig. 5

Effect of adjuvant immunochemotherapy with PSK on 5-year overall survival in patients with T2 or T3 gastric cancer after curative resection. Adapted and modified from Nakazato et al. [83]